These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23360820)

  • 1. Soluble α-klotho: a novel serum biomarker for the activity of GH-producing pituitary adenomas.
    Neidert MC; Sze L; Zwimpfer C; Sarnthein J; Seifert B; Frei K; Leske H; Rushing EJ; Schmid C; Bernays RL
    Eur J Endocrinol; 2013 Apr; 168(4):575-83. PubMed ID: 23360820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excessively high soluble Klotho in patients with acromegaly.
    Sze L; Bernays RL; Zwimpfer C; Wiesli P; Brändle M; Schmid C
    J Intern Med; 2012 Jul; 272(1):93-7. PubMed ID: 22452701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
    Kohler S; Tschopp O; Sze L; Neidert M; Bernays RL; Spanaus KS; Wiesli P; Schmid C
    Gen Comp Endocrinol; 2013 Jul; 188():282-7. PubMed ID: 23648743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone secreting pituitary microadenomas and empty sella - An under-recognized association?
    Liu W; Zhou H; Neidert MC; Schmid C; Bernays RL; Ni M; Zhou D; Jia W; Jia G
    Clin Neurol Neurosurg; 2014 Nov; 126():18-23. PubMed ID: 25194306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Alpha Klotho in Acromegaly: Comparison With Traditional Markers of Disease Activity.
    Schweizer JROL; Schilbach K; Haenelt M; Giannetti AV; Bizzi MF; Soares BS; Paulino E; Schopohl J; Störmann S; Ribeiro-Oliveira A; Bidlingmaier M
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2887-e2899. PubMed ID: 33864468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases.
    Wang M; Mou C; Jiang M; Han L; Fan S; Huan C; Qu X; Han T; Qu Y; Xu G
    Eur J Endocrinol; 2012 May; 166(5):797-802. PubMed ID: 22334636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D Volumetric Measurements of GH Secreting Adenomas Correlate with Baseline Pituitary Function, Initial Surgery Success Rate, and Disease Control.
    Tirosh A; Papadakis GZ; Chittiboina P; Lyssikatos C; Belyavskaya E; Keil M; Lodish MB; Stratakis CA
    Horm Metab Res; 2017 Jun; 49(6):440-445. PubMed ID: 28472827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone and Klotho.
    Schmid C; Neidert MC; Tschopp O; Sze L; Bernays RL
    J Endocrinol; 2013 Nov; 219(2):R37-57. PubMed ID: 24096965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aging suppressor klotho: a potential regulator of growth hormone secretion.
    Shahmoon S; Rubinfeld H; Wolf I; Cohen ZR; Hadani M; Shimon I; Rubinek T
    Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E326-34. PubMed ID: 24939736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
    Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
    Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of postoperative fluid diuresis in patients undergoing transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
    Zada G; Sivakumar W; Fishback D; Singer PA; Weiss MH
    J Neurosurg; 2010 Apr; 112(4):744-9. PubMed ID: 19698049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients.
    Shirvani M; Motiei-Langroudi R
    World Neurosurg; 2014 Jan; 81(1):125-30. PubMed ID: 23313263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly.
    Bellut D; Hlavica M; Schmid C; Bernays RL
    Neurosurg Focus; 2010 Oct; 29(4):E9. PubMed ID: 20887134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of exogenous growth hormone administration on circulating concentrations of α-klotho in healthy and chronic kidney disease subjects: a prospective, single-center open case-control pilot study.
    Adema AY; de Roij van Zuijdewijn CLM; Hoenderop JG; de Borst MH; Ter Wee PM; Heijboer AC; Vervloet MG;
    BMC Nephrol; 2018 Nov; 19(1):327. PubMed ID: 30442108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble delta-like 1 homolog decreases in patients with acromegaly following pituitary surgery: A potential mediator of adipogenesis suppression by growth hormone?
    Sze L; Tschopp O; Neidert MC; Bernays RL; Ghirlanda C; Zwimpfer C; Wiesli P; Schmid C
    Growth Horm IGF Res; 2019 Apr; 45():20-24. PubMed ID: 30818110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pituitary Is a Candidate Organ That Modulates Circulating Klotho Levels.
    Sato T; Komaba H; Nagatani T; Watanabe T; Kishida Y; Fukagawa M
    J Endocr Soc; 2019 Jan; 3(1):52-61. PubMed ID: 30697600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission.
    Pollock BE; Jacob JT; Brown PD; Nippoldt TB
    J Neurosurg; 2007 May; 106(5):833-8. PubMed ID: 17542527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.
    Kim EH; Oh MC; Lee EJ; Kim SH
    Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.